| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |